Letter by Zaghloul et al Regarding Article, "Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX"

Circ Cardiovasc Interv. 2022 Jul;15(7):e012098. doi: 10.1161/CIRCINTERVENTIONS.122.012098. Epub 2022 Jul 19.

Authors

Sheref Zaghloul¹, Nishil Patel², Mahmood Ahmad¹

Affiliations

¹ Department of Cardiology, Royal Free Hospital, London, United Kingdom (S.Z., M.A.).
² North Middlesex University Hospital, London, United Kingdom (N.P.).

PMID: 35861799
DOI: 10.1161/CIRCINTERVENTIONS.122.012098

No abstract available

Publication types

Letter
Comment

MeSH terms

Adenosine Monophosphate / adverse effects
Adenosine Monophosphate / analogs & derivatives
Humans
Percutaneous Coronary Intervention* / adverse effects
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Adenosine Monophosphate
cangrelor